Epidemiologist Þórólfur Guðnason says there is a negligible chance that a research project in collaboration with Pfizer will take place. This is what Þórólfur said to the news agency after a meeting between Þórólf, Kári Stefánsson, director of Icelandic Genetics, and Már Kristjánsson, chief physician of Landspítali’s infectious disease department with representatives of Pfizer. The meeting began at and it is just finished.
“I would say that there is a very small chance that this will happen, it has not been completely knocked off the table, but I think there is such a negligible chance,” said Þórólfur in a conversation with the news agency right after the meeting. He said issues had been discussed at the meeting but that no draft agreement was available. He could not answer whether a certain factor had put a dent in the account.
Victims of their own success
Kári Stefánsson, CEO of Icelandic Genetics , says that the reason is that the case of Covid – in Iceland are simply not many enough. He does not expect to enter into negotiations with other pharmaceutical companies, as he would face the same arguments, which are difficult to refute.
“We are a victim of our own success,” says Kári. “If we had about twenty cases a day, this would have worked.”
“I am have been saying it all along, either it works or it doesn’t work. Despite all these stories, there has been no agreement or draft agreement on the table. We were just discussing issues and we will only explain this in the near future, “said Þórólfur.
He then reiterated that he considered it rather unlikely that it would be from the fourth phase of the Pfizer study in question here. on land. It was hoped that such a study could guarantee a dry Icelanders dose of Pfizer and BioNTech vaccine against Covid – 08 in the coming months. There has been a lot of anticipation after the results of the negotiations between Pfizer, the epidemiologist and Kári, and there has been a response from the pharmaceutical manufacturer for several weeks.
The news is being processed.
Kári Stefánsson, director of Icelandic Genetics, Már Kristjánsson, chief physician of Landspítali’s infectious diseases department and Þórólfur Guðnason, epidemiologist, meet with scientists from the pharmaceutical company Pfizer at 016 today.